RGC
Regencell Bioscience Holdings Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$23.23
-0.77 ▼ -3.21%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$23.03
-0.20 ▼ -0.86%
| Index | - | P/E | - | EPS (ttm) | -0.01 | Insider Own | 88.56% | Shs Outstand | 0.49B | Perf Week | -0.51% |
| Market Cap | 11.49B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.06B | Perf Month | -13.06% |
| Enterprise Value | 11.48B | PEG | - | EPS next Q | - | Inst Own | 0.11% | Short Float | 1.12% | Perf Quarter | 41.99% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | -8.67% | Short Ratio | 1.39 | Perf Half Y | 72.71% |
| Sales | 0.00B | P/B | 2363.17 | EPS next 5Y | - | ROA | -50.5% | Short Interest | 0.63M | Perf YTD | 10.62% |
| Book/sh | 0.01 | P/C | 2344.28 | EPS past 3/5Y | 22.39% -33.47% | ROE | -54.81% | 52W High | -72.21% ($83.60) | Perf Year | 6165.01% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -70.39% | 52W Low | 20239.63% ($0.11) | Perf 3Y | 3231.09% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.24% | Gross Margin | - | Volatility(W/M) | 16.02% 11.16% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.39 | EPS Q/Q | 22.22% | Profit Margin | - | RSI (14) | 42.31 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.39 | Sales Q/Q | - | SMA20 | -12.93% ($26.68) | Beta | 2.22 | Target Price | - |
| Payout | - | Debt/Eq | 0.11 | Earnings | - | SMA50 | -19.73% ($28.94) | Rel Volume | 0.2 | Prev Close | $24 |
| Employees | 10 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | - | SMA200 | 16.99% ($19.86) | Avg Volume(3M) | 0.46M | Price | $23.23 |
| IPO | 2021/7/16 | Option/Short | Yes/Yes | Trades | 1421 | Volume | 89,585 | Change | -3.21% |
뉴스 로딩 중...